Dovato and Helicobacter infection - a phase IV clinical study of FDA data

Summary:

Helicobacter infection is reported as a side effect among people who take Dovato (dolutegravir sodium; lamivudine), especially for people who are male, 30-39 old, also take Estradiol, and have Rash macular.

The phase IV clinical study analyzes which people have Helicobacter infection when taking Dovato. It is created by eHealthMe based on reports of 2,525 people who have side effects when taking Dovato from the FDA, and is updated regularly.

What is Dovato?

Dovato has active ingredients of dolutegravir sodium; lamivudine. It is often used in hiv infection. eHealthMe is studying from 2,537 Dovato users. Check the latest studies of Dovato.

What is Helicobacter infection?

Helicobacter infection (helicobacter pylori (h. pylori) infects stomach) is found to be associated with 637 drugs and 615 conditions by eHealthMe. Check the latest studies of Helicobacter infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

2,525 people reported to have side effects when taking Dovato.
Among them, 16 people (0.63%) have Helicobacter infection.

Could Dovato cause Helicobacter infection?

Among these 16 people:

What is the gender of people who have Helicobacter infection when taking Dovato? *

female: 0.0 %
male: 100 %

What is the age of people who have Helicobacter infection when taking Dovato? *

What are other drugs people take besides Dovato? *

What are other side effects people have besides Helicobacter infection? *

Fever: 12 people, 75.00%
Helicobacter Gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium): 11 people, 68.75%
Autoimmune Hepatitis: 9 people, 56.25%
General Physical Health Deterioration (weak health status): 9 people, 56.25%
Rashes (redness): 6 people, 37.50%
High Blood Pressure: 4 people, 25.00%
Folliculitis (infection of hair root): 4 people, 25.00%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 4 people, 25.00%
Herpes Zoster: 4 people, 25.00%
Abdominal Distension: 4 people, 25.00%

What are the existing conditions these people have? *

Rash Macular (small, flat red spots): 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Dovato and have Helicobacter infection?

- Check whether Helicobacter infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dovato:

Dovato (2,537 reports)

Helicobacter infection treatments and more:

Helicobacter infection (15,777 reports)

How severe was Helicobacter infection and when was it recovered:

Helicobacter infection in Dovato

Expand to all the drugs that have ingredients of dolutegravir sodium; lamivudine:

Helicobacter infection and drugs with ingredients of dolutegravir sodium; lamivudine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dovato:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Helicobacter infection:

Helicobacter infection (638 drugs)

Browse all the conditions that are associated with Helicobacter infection:

Helicobacter infection (615 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dolutegravir sodium; lamivudine (the active ingredients of Dovato) and Dovato (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.